Name: Primolut N 5mg (Norethisterone) X30
Price: 11500 NGN
Availability: InStock

Primolut N is a brand name for Norethisterone, a synthetic progestin hormone. This medication is used for various gynecological purposes, including contraception, treatment of menstrual disorders, and in some cases, as part of breast cancer treatment. Primolut N works by altering the body’s natural hormone levels to regulate the menstrual cycle and prevent pregnancy.

Uses

Primolut N is prescribed for contraception, treatment of menstrual disorders such as irregular or heavy periods, management of endometriosis symptoms, hormone replacement therapy in certain cases, and as an adjunct treatment in specific breast cancer cases.

Benefits

Effective contraception when used as directed
Helps regulate menstrual cycles
Reduces heavy menstrual bleeding
Alleviates symptoms associated with endometriosis
May be beneficial in certain breast cancer treatment regimens

How it works

Norethindrone, the active ingredient in Primolut N, mimics the effects of natural progesterone in the body. It works by altering the lining of the uterus and cervical mucus, making it difficult for sperm to reach an egg and for a fertilized egg to implant. This hormone also helps regulate the menstrual cycle and can reduce excessive bleeding.

Dosage

The dosage of Primolut N varies depending on the condition being treated and individual patient factors. Always follow your healthcare provider’s instructions carefully. Typical dosages may range from 0.35 mg to 5 mg daily, but this can vary significantly based on the specific use case.

Side Effects

Common side effects may include nausea, bloating, breast tenderness, changes in weight, headaches, and mood changes. If these side effects persist or worsen, consult your healthcare provider.

Warning

Primolut N is not suitable for everyone. It should not be used by women who are pregnant, have undiagnosed vaginal bleeding, or have a history of certain cancers or blood clots. This medication may increase the risk of blood clots, especially in smokers over 35 years old. It does not protect against sexually transmitted infections.

Important Information

Inform your healthcare provider about your complete medical history and all medications you are taking before starting Primolut N. Regular check-ups are important while using this medication. If you are using Primolut N for contraception, an additional barrier method is recommended to protect against sexually transmitted infections.

Not intended for use in children. Metropathia haemorrhagica (dysfunctional uterine bleeding): 1 tablet 3 times daily for 10 days. Bleeding is arrested usually within 1-3 days. A withdrawal bleeding resembling normal menstruation occurs within 2-4 days after discontinuing treatment. One tablet twice daily from the 19^th to the 26^th day of the two subsequent cycles should be given to prevent recurrence of the condition. To ensure treatment success, Primolut N must be taken for the full 10 days. Occasionally, slight bleeding may occur after the initial suspension of bleeding. Treatment should not be interrupted or suspended in these cases. If vaginal bleeding does not stop, despite correct tablet intake, an organic cause or an extra-genital factor (e.g. polyps, carcinoma of the cervix uteri or endometrium, myoma, residua of abortion, extra-uterine pregnancy, or coagulation disorders) must be considered so that other measures are then mostly required. This also applies to cases where after an initial suspension of bleeding, fairly heavy bleeding reoccurs during tablet intake. Premenstrual syndrome (including premenstrual mastalgia): Premenstrual symptoms such as headache, migraine, breast discomfort, water retention, tachycardia, and psychological disturbances may be relieved by the administration of 1-3 tablets daily from the 19^th to the 26^th day of the cycle. Treatment should be repeated for several cycles. When treatment is stopped, the patient may remain symptom-free for a number of months. Postponement of menstruation: In cases of too frequent menstrual bleeding, and in special circumstances (e.g. operations, travel, sports) the postponement of menstruation is possible. The dosage is 1 tablet of Primolut N three times daily, starting 3 days before the expected onset of menstruation and continuing for not longer than 10 to 14 days. A normal period should occur 2-3 days after the patient has stopped taking tablets. This method should be restricted to users who are not at risk of pregnancy during the treatment cycle. Endometriosis (pseudo-pregnancy therapy): Treatment should begin between the first and 5th day of the cycle with 1 of tablet Primolut N twice daily. In the event of spotting, the dose can be increased to 2 tablets twice daily. If bleeding ceases, dose reduction to the initial dose should be considered. Treatment is to be continued for at least 4 to 6 months. With uninterrupted daily intake, ovulation and menstruation do not usually occur. Menorrhagia (hypermenorrhoea): 1 tablet 2-3 times a day from the 19^th to the 26^th day of the cycle (counting the first day of menstruation as day 1). Dysmenorrhoea: Functional or primary dysmenorrhoea is almost invariably relieved by the suppression of ovulation. 1 tablet three times daily for 20 days, starting on the fifth day of the cycle (the first day of menstruation counting as day 1). Treatment should be maintained for three to four cycles followed by treatment-free cycles. A further course of therapy may be employed if symptoms return. Method of administration Oral use. The tablets are to be swallowed whole with some liquid.